Baker Avenue Asset Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$387K Sell
1,631
-615
-27% -$128K 0.01% 593
2026
Q1
$475K Buy
2,246
+917
+69% +$197K 0.01% 448
2025
Q4
$273K Buy
+1,329
New +$250K 0.01% 532
2023
Q4
Sell
-46
Closed -$3.99K 536
2023
Q3
$3.99K Sell
46
-22
-32% -$1.99K ﹤0.01% 992
2023
Q2
$6.43K Buy
68
+22
+48% +$1.86K ﹤0.01% 806
2023
Q1
$3.47K Hold
46
﹤0.01% 903
2022
Q4
$3.54K Buy
+46
New +$3.5K ﹤0.01% 860

Other funds holding CAH

Baker Avenue Asset Management's CAH Position: Q2 2026 in Review

Baker Avenue Asset Management reduced its Cardinal Health (CAH) stake by 27% in Q2 2026, selling an estimated $128K and leaving 1,631 shares worth $387K. The position accounts for 0.01% of the portfolio, ranked #593.

Baker Avenue Asset Management first reported a position in CAH in Q4 2022 and has held it in 7 quarters since. The position peaked at $475K in Q1 2026. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Baker Avenue Asset Management held 1,631 shares of Cardinal Health worth $387K as of Q2 2026.
  • Baker Avenue Asset Management sold 615 Cardinal Health shares in Q2 2026, an estimated $128K.
  • Cardinal Health made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #593 holding.
  • Baker Avenue Asset Management first reported a position in Cardinal Health in Q4 2022 and has held it in 7 quarters since.
  • Baker Avenue Asset Management's Cardinal Health position peaked at $475K in Q1 2026.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.